The stock's fall snapped a two-day winning streak.

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...

Shares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) have received an average recommendation of “Hold” from the seven ...

The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

In this article, we are going to take a look at where Novavax, Inc. (NASDAQ:NVAX) stands against other unstoppable stocks that could double your money. Generating significant returns and ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...